Resveratrol in Type2 Diabetes and Obesity
Stopped FDA clinical hold requiring IND submission, product not available in the market anymore
Conditions
- Type 2 Diabetes
- Obesity
- Insulin Resistance
Interventions
- DRUG: Placebo
- DRUG: Resveratrol 40 mg oral three times a day
- DRUG: Resveratrol 500 mg oral once daily.
Sponsor
University at Buffalo
Collaborators